Novus International, Inc. recently announced the launch of SPORULIN® Direct-Fed Microbial (DFM) for the poultry industry. This new DFM was developed at the University of Arkansas after five years of research and is currently manufactured by Pacific Vet Group-USA. Novus has the exclusive distribution rights in most markets around the world. Novus is proud to add SPORULIN direct-fed microbial to its industry-leading poultry gut health portfolio.
The research behind the development of SPORULIN involved screening literally millions of potential isolates against rigorous selection criteria, followed by extensive laboratory and field testing. The result was a unique, proprietary blend of three specifically selected strains of Bacillus subtilis that work well in combination and, more importantly, perform well in the animal. SPORULIN delivers the optimal blend of a perfected combination of spores to just the right location in the gut, leading to optimized feed conversion, maximized health and improved food safety.
Many probiotic formulations used in commercial poultry production are pre-defined cultures that were originally developed for some other purpose. SPORULIN, however, is a custom-designed, purpose-built probiotic for modern poultry production.
SPORULIN is very tolerant to the heat and pressure of feed manufacturing and has a high post-pelleting potency and stability profile. The spores are robust and can survive harsh conditions during feed pelleting and storage, and they can sporulate and grow to large numbers quickly in the gastrointestinal track of the animal. The product has a positive effect on Clostridium spp. and Salmonella spp.
In field tests among broilers and turkeys, SPORULIN has been shown to help maximize weight gain, optimize feed conversion, have a positive effect on Clostridium perfringens in commercial poultry and decrease the incidence of food safety associated pathogens.
"We're excited about offering poultry producers a truly innovative probiotic that will help improve the performance of their birds," said Ted Toburen, Senior Director Therapeutic Nutrition Solutions, at Novus. "SPORULIN will also deliver a more reliable effect on Salmonella and Clostridium perfringens, with more consistent results when compared to other probiotics currently on the market."
For more information visit www.novusint.com